Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 18.47% is 45% below its 5-year average of 33.43%, near the low end of its 5-year range (12.26%–48.99%).
4.27% below its 12-month average of 19.29%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.82%.
OPERATING MARGIN
18.47%
OPERATING MARGIN AVG TTM
19.29%
OPERATING MARGIN AVG 3Y
26.60%
OPERATING MARGIN AVG 5Y
33.43%
OPERATING MARGIN AVG 10Y
31.39%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-4.27%
CURRENT VS 3Y AVG
-30.56%
CURRENT VS 5Y AVG
-44.75%
CURRENT VS 10Y AVG
-41.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$807.96M
Operating Margin
-7.86%
TTM Avg
-9.22%
3Y Avg
-47.88%
5Y Avg
-486.53%
Market Cap
$792.17M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
Market Cap
$821.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$790.46M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
Market Cap
$823.91M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$832.31M
Operating Margin
-69.75%
TTM Avg
-70.49%
3Y Avg
-9306.05%
5Y Avg
-9306.05%
Market Cap
$769.83M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMode Ltd. (INMD) | $805.89M | 18.47% | 19.29% | 26.60% | 33.43% |
| Ardelyx, Inc. (ARDX)vs › | $807.96M | -7.86% | -9.22% | -47.88% | -486.53% |
| Apnimed, Inc. (APMD)vs › | $811.99M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $792.17M | -0.31% | 6.92% | 0.39% | 2.91% |
| Jade Biosciences, Inc. (JBIO)vs › | $821.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $790.46M | 9.86% | 12.61% | -6.26% | -239.99% |
| Alumis Inc. (ALMS)vs › | $823.91M | -1776.32% | -888.16% | -444.08% | -444.08% |
| Beta Bionics, Inc. (BBNX)vs › | $832.31M | -69.75% | -70.49% | -9306.05% | -9306.05% |
| Geron Corporation (GERN)vs › | $769.83M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | -98.21% | -366.21% | -21871.64% | -19485.10% |
Gross Margin
76.5%
Operating Margin
18.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 12.82% |
| 2026-03-31 | 12.26% |
| 2025-12-31 | 25.03% |
| 2025-09-30 | 22.43% |
| 2025-06-30 | 23.93% |
| 2025-03-31 | 20.06% |
| 2024-12-31 | 28.48% |
| 2024-10-31 | 37.06% |
| 2024-06-30 | 21.18% |
| 2024-03-31 | 22.54% |
| 2023-12-31 | 40.42% |
| 2023-09-30 | 37.70% |
| 2023-06-30 | 41.89% |
| 2023-03-31 | 38.65% |
| 2022-12-31 | 44.84% |
| 2022-09-30 | 44.33% |
| 2022-06-30 | 43.33% |
| 2022-03-31 | 40.74% |
| 2021-12-31 | 48.99% |
| 2021-09-30 | 47.80% |
| 2021-06-30 | 47.56% |
| 2021-03-31 | 40.86% |
| 2020-12-31 | 47.14% |
| 2020-09-30 | 39.01% |
| 2020-06-30 | 26.34% |
| 2020-03-31 | 14.84% |
| 2019-12-31 | 38.25% |
| 2019-09-30 | 39.94% |
| 2019-06-30 | 40.54% |
| 2019-03-31 | 32.51% |
| 2018-12-31 | 4.56% |
| 2018-09-30 | 33.02% |
| 2018-06-30 | 31.31% |
| 2018-03-31 | 28.40% |
| 2017-12-31 | 18.79% |
| 2017-09-30 | 19.80% |
| 2017-06-30 | 22.97% |
| 2017-03-31 | 12.39% |
